Get started
Author

Jeffrey W. Hunter

Observed names: Jeffrey Hunter, Jeffrey W Hunter
ORCID: 0000-0002-3898-6632
Observed ORCID: 0000-0002-3898-6632
OpenAlex ID: A5087969247
Activin-dependent signaling in fibro/adipogenic progenitors causes fibrodysplasia ossificans progressiva
2018 · John B. Lees-Shepard, Masakazu Yamamoto, et al. · Nature Communications · 228
PDF
A TPO Receptor Agonist, ALXN4100TPO, Mitigates Radiation-Induced Lethality and Stimulates Hematopoiesis in CD2F1 Mice
2011 · Merriline Satyamitra, Eric Lombardini, et al. · Radiation Research · 37
An ALK2 inhibitor, BLU-782, prevents heterotopic ossification in a mouse model of fibrodysplasia ossificans progressiva
2024 · Alison J. Davis, Natasja Brooijmans, et al. · Science Translational Medicine · 21
Plasma-Soluble Biomarkers for Fibrodysplasia Ossificans Progressiva (FOP) Reflect Acute and Chronic Inflammatory States
2020 · Robert J Pignolo, Ruth McCarrick-Walmsley, et al. · Journal of Bone and Mineral Research · 15
Characterization of the bispecific VHH antibody tarperprumig (ALXN1820) specific for properdin and designed for low-volume administration
2024 · Paul Tamburini, Dennis Vestergaard Pedersen, et al. · mAbs · 7
Sex as a Critical Variable in Basic and Pre-Clinical Studies of Fibrodysplasia Ossificans Progressiva
2024 · Lorraine N Burdick, Amanda H Delvichio, et al. · Biomolecules · 3
PDF
Increasing Upstream Process Development Efficiency by Implementing Platform Glutamine Synthetase Cell Culture Processes
2010 · Robert Heckathorn, Derek Adams, et al. · Springer eBooks · 2
Works count: 7
Citation count: 313
H-index: 5
I10-index: 4
Year
Topic
Type